CRISPR Therapeutics AG

CRISPR Therapeutics AG

World Rank (Jan-05-2024)
2,937
Market Cap (Jan-05-2024)
4.970 Billion USD
World Rank (Jul-30-2023)
3,257
Market Cap (Jul-30-2023)
4.491 Billion USD
World Rank (Jan-07-2022)
3,187
Market Cap (Jan-07-2022)
5.178 Billion USD
World Rank (Jan-01-2021)
1,581
Market Cap (Jan-01-2021)
10.903 Billion USD
Headquarters Country
Switzerland
Nasdaq / NYSE Code
CRSP
Market Cap (Mar-08-2026)
5.42
Employee Count
458
Employee Count as of Date
As on 2022
World Region
Europe
World Subregion
Western Europe
Annual Revenue in USD
914 Million USD
Annual Net Income in USD
377 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
2,751 Million USD
Total Liabilities in USD
352 Million USD
Total Equity in USD
2,399 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Website
CRISPR THERAPEUTICS AG
Yahoo
Yahoo @ Nasdaq
Company Profile

Biotechnology company and gene editing company to control couple of human diseases like Cancer and couple of other diseases and it's headquarters is in Switzerland.

With CRISPR/Cas9, they aim to target the source of genetically-defined diseases and engineer the next generation of cellular therapies

Founded Year
2013
IPO Year
2016
Stock Exchange
Nasdaq
Company SubCategory
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Biological Products (No Diagnostic Substances)

Share